Literature DB >> 22958878

HLA-A, -B, -DR allele group frequencies in 7007 kidney transplant list patients in 27 UK centres.

C Burt1, C Cryer, S Fuggle, A-M Little, P Dyer.   

Abstract

This observational study aims to determine the HLA specificity frequencies of patients on the UK renal transplant list, which can be used as a resource for those laboratories that support the UK renal transplant programme. Whilst the HLA specificity frequencies may differ from that of the general population, it is the individuals on the transplant list who are in need of a new kidney, which has to be provided from the general population. Any differences in protein allele frequencies between this patient population and the general population are likely to be minimal because of the very large number of patients included. The HLA-A, -B and -DR allele group frequencies from 7007 patients on the UK kidney transplant list (August, 2009) were analysed. HLA types had been submitted to NHSBT to register patients on the UK deceased donor kidney waiting list. The data were submitted from 27 different registering centres throughout the UK. Within this data set, 25 different HLA-A, 50 HLA-B and 18 HLA-DR allele groups were present. The most common allele groups at each locus were -A2 (phenotype frequency 42.6%), -B44 (phenotype frequency 23.3%) and -DR4 (phenotype frequency 29.8%). The least common allele groups at each locus were -A19, - A43, -B16, -B21, -B22, -B83 and -DR5. Reports of HLA frequency (protein allotype) data from populations as large as this are not readily available adding value to this observational study.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22958878     DOI: 10.1111/iji.12000

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  8 in total

Review 1.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

2.  Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.

Authors:  Séverine Bézie; Béatrice Charreau; Nadège Vimond; Juliette Lasselin; Nathalie Gérard; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Franck Duteille; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2019-11-26

Review 3.  Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.

Authors:  Ilse Gille; Frans H J Claas; Geert W Haasnoot; Mirjam H M Heemskerk; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 4.  Biomarkers of immune tolerance in kidney transplantation: an overview.

Authors:  Wee-Song Yeo; Qin Xiang Ng
Journal:  Pediatr Nephrol       Date:  2021-03-12       Impact factor: 3.714

5.  High resolution HLA haplotyping by imputation for a British population bioresource.

Authors:  Matt J Neville; Wanseon Lee; Peter Humburg; Daniel Wong; Martin Barnardo; Fredrik Karpe; Julian C Knight
Journal:  Hum Immunol       Date:  2017-01-19       Impact factor: 2.850

Review 6.  Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.

Authors:  Yi Dong; Cuiping Yang; Fan Pan
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

7.  Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial.

Authors:  Ellen Gorman; Manu Shankar-Hari; Phil Hopkins; William S Tunnicliffe; Gavin D Perkins; Jonathan Silversides; Peter McGuigan; Anna Krasnodembskaya; Colette Jackson; Roisin Boyle; Jamie McFerran; Cliona McDowell; Christina Campbell; Margaret McFarland; Jon Smythe; Jacqui Thompson; Barry Williams; Gerard Curley; John G Laffey; Mike Clarke; Daniel F McAuley; Cecilia M O'Kane
Journal:  EClinicalMedicine       Date:  2021-10-24

Review 8.  Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.

Authors:  Qunfang Zhang; Weihui Lu; Chun-Ling Liang; Yuchao Chen; Huazhen Liu; Feifei Qiu; Zhenhua Dai
Journal:  Front Immunol       Date:  2018-10-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.